alexa Brittney-Shea Herbert | Indiana University School of Me
ISSN: 2157-2518

Journal of Carcinogenesis & Mutagenesis
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Brittney-Shea Herbert

Brittney-Shea Herbert Brittney-Shea Herbert
Associate Professor
Department of Medical and Molecular Genetics
Indiana University School of Medicine
USA
Tel: 317-278-6147
Fax: 317-274-1069
Biography

Dr Brittney Shea Herbert is currently an Associate Professor of Medical and Molecular Genetics and Pharmacology and Toxicology at the Indiana University School of Medicine.She is  a Member of the Indiana University IU Melvin and Bren Simon Cancer Center and a Member of the Center for Regenerative Biology and Medicine. Dr.  Herbert obtained her B A and PhD degrees in Biological Sciences with a focus on nutrition and cancer from the University of Texas at Austin.  Dr. Herbert then performed postdoctoral research on telomeres and telomerase under the tutelage of Drs. Jerry Shay and Woodring Wright at The University of Texas Southwestern Medical Center at Dallas Department of Cell Biology.  Among Dr. Herbert’s honors, some are a NASA Graduate Student Research Fellowship, a Susan G Komen Breast Cancer Fellowship, a DOD Breast Cancer Research Program Postdoctoral Fellowship and numerous grants awarded for research in breast cancer.

Research Interest

Dr. Herbert’s current research interests are the role of telomeres and telomerase in aging and cancer, with particular interests in cancer progression, inherited breast cancers, novel cancer therapeutic agents as well as preclinical models for cancer research. One of the oligonucleotide telomerase inhibitors investigated by Dr. Herbert’s laboratory is currently in clinical trials for cancer, including a breast cancer clinical trial at the IU Simon Cancer Center.

Certificate
Certificate

Global Speakers in the subject

Global Experts in the subject

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords